Prognostic Factors in Stage III Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Prognostic Factors in Stage III Non–Small-Cell Lung Cancer

Published:2007-09 Issue:8 Volume:8 Page:478-482
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Ademuyiwa Foluso O.,Johnson Cynthia S.,White Angela S.,Breen Timothy E.,Harvey Jayme,Neubauer Marcus,Hanna Nasser H.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference34 articles.

1. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer;Schaake-Koning;N Engl J Med,1992

2. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410;Curran;Proc Am Soc Clin Oncol,2003

3. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer;Furuse;J Clin Oncol,1999

4. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study;Fournel;J Clin Oncol,2005

5. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol;Belani;J Clin Oncol,2005

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Response to Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer: A Prospective Cohort Study;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2024

2. The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non–small cell lung cancer: A multicenter retrospective cohort study;Clinical and Translational Radiation Oncology;2022-11

3. Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC;npj Precision Oncology;2022-10-27

4. The Time-series Behavior of Systemic Inflammation-immune Status in Predicting Survival of Locally Advanced Non-small Cell Lung Cancer Treated with Chemoradiotherapy;Journal of the National Cancer Center;2021-11

5. Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population;Cancer Research and Treatment;2021-10-15